Literature DB >> 19847565

Resection margin and recurrence-free survival after liver resection of colorectal metastases.

Andrea Muratore1, Dario Ribero, Giuseppe Zimmitti, Alfredo Mellano, Serena Langella, Lorenzo Capussotti.   

Abstract

BACKGROUND: Optimal margin width is uncertain because of conflicting results from recent studies using overall survival as the end-point. After recurrence, re-resection and aggressive chemotherapy heavily affect survival time; the potential confounding effect of such factors has not been investigated. Use of recurrence-free survival (RFS) may overcome this limitation. The aim of this study is to evaluate the impact of width of resection margin on RFS and site of recurrence after hepatic resection for colorectal metastases (CRM).
METHODS: From a prospectively maintained institutional database (1/1999-12/2007) we identified 314 patients undergone hepatectomy for CRM (1/1999-12/2007) with detailed pathologic analysis of the surgical margin and complete follow-up imaging studies documenting disease status and site of recurrence, which was categorized as: resection margin (M(arg)), other intra-hepatic ((other)IH), lung (L) or other extra-hepatic ((other)EH). Recurrence-free estimation was the survival end-point.
RESULTS: Median follow-up was 56.5 months. Two hundred and fifteen patients (68.8%) recurred at 288 sites after a mean of 15.5 months. A positive resection margin was associated with an increased risk of M(arg) recurrence (P < 0.001). The presence of >or=2 metastases was the only factor increasing the risk of positive margins (P < 0.05). The width of the negative resection margin (>or=1 cm versus >1 cm) was not a prognostic factor of worse RFS (30.2% versus 37.3%, P = 0.6). Node status of the primary tumour, and size and number of CRM were independent predictors of RFS.
CONCLUSIONS: Tumour biology and not the width of the negative resection margin affect RFS.

Entities:  

Mesh:

Year:  2009        PMID: 19847565     DOI: 10.1245/s10434-009-0770-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  52 in total

1.  Safety analysis of the oncological outcome after vein-preserving surgery for colorectal liver metastases detached from the main hepatic veins.

Authors:  Federico Tomassini; Italo Bonadio; Peter Smeets; Karen De Paepe; Giammauro Berardi; Liesbeth Ferdinande; Stéphanie Laurent; Louis J Libbrecht; Karen Geboes; Roberto I Troisi
Journal:  Langenbecks Arch Surg       Date:  2015-08-12       Impact factor: 3.445

Review 2.  Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.

Authors:  Elena Nadia Petre; Constantinos Sofocleous
Journal:  Visc Med       Date:  2017-02-03

3.  Robot-assisted parenchymal-sparing liver surgery including lesions located in the posterosuperior segments.

Authors:  Luciano Casciola; Alberto Patriti; Graziano Ceccarelli; Alberto Bartoli; Cecilia Ceribelli; Alessandro Spaziani
Journal:  Surg Endosc       Date:  2011-06-08       Impact factor: 4.584

Review 4.  Segmentectomy: is minimally invasive surgery going to change a liver dogma?

Authors:  Fulvio Calise; Antonio Giuliani; Loredana Sodano; Enrico Crolla; Paolo Bianco; Aldo Rocca; Antonio Ceriello
Journal:  Updates Surg       Date:  2015-07-22

5.  Resection margin with anatomic or nonanatomic hepatectomy for liver metastasis from colorectal cancer.

Authors:  Yoshihiro Inoue; Michihiro Hayashi; Koji Komeda; Shinsuke Masubuchi; Masashi Yamamoto; Hidenori Yamana; Hajime Kayano; Tetsunosuke Shimizu; Mitsuhiro Asakuma; Fumitoshi Hirokawa; Yoshiharu Miyamoto; Atsushi Takeshita; Yuro Shibayama; Kazuhisa Uchiyama
Journal:  J Gastrointest Surg       Date:  2012-02-28       Impact factor: 3.452

6.  Intraoperative margin re-resection for colorectal cancer liver metastases.

Authors:  Sajid A Khan; Jeffrey B Matthews
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

7.  Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy.

Authors:  Ilia Gur; Brian S Diggs; Jesse A Wagner; Gina M Vaccaro; Charles D Lopez; Brett C Sheppard; Susan L Orloff; Kevin G Billingsley
Journal:  J Gastrointest Surg       Date:  2013-10-04       Impact factor: 3.452

8.  Incidence and treatment of local site recurrences following RFA of colorectal liver metastases.

Authors:  Karin Nielsen; Aukje A J M van Tilborg; Martijn R Meijerink; Matessa O Macintosh; Babs M Zonderhuis; Elly S M de Lange; Emile F I Comans; Sybren Meijer; M Petrousjka van den Tol
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

9.  Radiofrequency vessel-sealing system versus the clamp-crushing technique in liver transection: results of a prospective randomized study on 100 consecutive patients.

Authors:  Andrea Muratore; Alfredo Mellano; Giuseppe Tarantino; Patrizia Marsanic; Michele De Simone; Fabrizio Di Benedetto
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

10.  Influence of margins on disease free survival following hepatic resection for colorectal metastasis: a meta-analysis.

Authors:  Mashaal Dhir; Elizabeth R Lyden; Lynette M Smith; Chandrakanth Are
Journal:  Indian J Surg Oncol       Date:  2012-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.